GILEAD SCIENCES, INC. Current Assets
GILEAD SCIENCES, INC. (GILD) had Current Assets of $13.95 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $13.95B.
- 2026-03-31: Assets, Current $18.64B.
- 2025-12-31: Assets, Current $18.34B.
- 2025-09-30: Assets, Current $17.87B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.95B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $18.64B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $18.34B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $17.87B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $14.72B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $16.90B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $19.17B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $14.78B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $12.32B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $14.04B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $16.09B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $15.98B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $14.29B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $13.46B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $14.44B 10-K · filed 2024-02-23 | |
| 2022-09-30 | $13.55B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $13.18B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $12.63B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $14.77B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $13.99B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $13.93B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $13.28B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $16.00B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $30.93B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $24.64B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $26.95B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $30.30B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $28.36B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $33.73B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $34.02B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $35.84B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $34.92B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $32.73B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $30.26B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $31.82B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $35.32B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $28.59B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $21.42B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $19.59B 10-K · filed 2018-02-27 | $20.45B 10-K · filed 2017-02-27 |
| 2016-09-30 | $21.43B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $18.35B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $19.27B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $24.76B 10-K · filed 2017-02-27 | $24.76B 10-K · filed 2016-02-24 |
| 2015-09-30 | $25.91B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $18.09B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $20.06B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $17.71B 10-K · filed 2016-02-24 | |
| 2014-09-30 | $12.56B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $15.50B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $12.97B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $7.00B 10-K · filed 2015-02-25 | $7.27B 10-K · filed 2014-02-25 |
| 2013-09-30 | $6.97B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $7.07B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $6.66B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $6.16B 10-K · filed 2014-02-25 | |
| 2012-09-30 | $5.88B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $5.84B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $5.83B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $13.92B 10-K · filed 2013-02-27 | |
| 2011-09-30 | $6.15B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $6.22B 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $6.85B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $5.71B 10-K · filed 2012-02-23 | |
| 2010-09-30 | $6.03B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $5.71B 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $5.12B 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $4.81B 10-K · filed 2011-02-28 | |
| 2009-09-30 | $4.30B 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $4.00B 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $4.28B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |